iSOFT Wins $14 Million New Business in Europe

iSOFTiSOFT, an IBA Health Group company (ASX: IBA) announced that it has secured new business together with renewal of contracts worth AS$14 million in the UK and central Europe over the past month. iSOFT Northern Europe has had a record month of new orders worth AS$5 million (€3.1 million), while iSOFT UK and Ireland has agreed contract extensions worth AS$9 million (£4.22 million) for ongoing maintenance and support.

New orders for iSOFT Northern Europe included six contracts in Germany for hospital information systems. The company also won four orders for radiology information systems with three hospitals in Germany and with Euromedic in Switzerland for three of its diagnostic centres.

Four contracts for laboratory information systems were also secured with three hospitals in Germany and Gemotest in Russia.

Albertinen Gruppe in Hamburg has agreed a contract for iSOFT's Professional Planner for intelligent financial planning across three sites.

In the UK and Ireland, Harrogate Healthcare NHS Trust and South Tyneside Healthcare NHS Trust have agreed five year licence and support contracts for iSOFT patient management systems and the Southern Health Board in Ireland and St George's Healthcare NHS Trust in London have renewed support agreements for iSOFT laboratory information systems.

Gary Cohen, IBA's Executive Chairman and CEO, said: "We have had an excellent month of new business in Northern Europe, a record for the company and clear evidence of a renewed confidence in iSOFT."

Related news articles:

About IBA Health Group
IBA Health Group Limited (ASX-IBA) is the largest specialist information technology company listed on the Australian Securities Exchange.

IBA builds software applications for healthcare. We work with healthcare professionals to design and build solutions that answer all of the difficult questions posed by today's care delivery challenges. Our solutions act as a catalyst for change, supporting the exchange of critical information across diverse care settings and participant organisations. We are the leader in the provision of advanced application solutions in modern healthcare economies around the world.

Today, over 13,000 provider organisations in 35 countries across five continents use IBA's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of our market and anticipation of evolving requirements. Our business is driven by the collective talent, experience and commitment of over 3,500 healthcare IT experts around the globe.

A global network of IBA subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result we offer our customers comprehensive knowledge of local market requirements, in terms of culture, language, working practice, healthcare regulation and organisational structure.

For more information on IBA Health, please visit the Company's website at www.ibahealth.com.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

A Machine Learning Tool for Diagnosing, …

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people. The analysis...

Fine-Tuned LLMs Boost Error Detection in…

A type of artificial intelligence (AI) called fine-tuned large language models (LLMs) greatly enhances error detection in radiology reports, according to a new study published in Radiology, a journal of...

DeepSeek-R1 Offers Promising Potential t…

A joint research team from The Hong Kong University of Science and Technology and The Hong Kong University of Science and Technology (Guangzhou) has published a perspective article in MedComm...

Deep Learning can Predict Lung Cancer Ri…

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference...